IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE

IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE

Show other versions (1)

<p><strong>Aim.</strong> To estimate the role of immuno-inflammatory response in developing of angina pectoris in patients with ischemic heart disease (IHD).</p><p><strong>Material and methods:</strong> The study included 83 patients with IHD and angina pect...

Full description

Bibliographic Details
Main Authors:	N. E. Zakirova, N. Kh. Khafizova, I. M. Karamova, A. N. Zakirova, R. G. Oganov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	ишемическая болезнь сердца стенокардия иммуновоспалительные реакции цитокины
Online Access:	http://www.rpcardio.ru/jour/article/view/405

Similar Items

IMMUNO-INFLAMATORY RESPONSES IN ACUTE CORONARY SYNDROME
by: R. G. Oganov, et al.
Published: (2015-12-01)

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-09-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015-12-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-12-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)

A CLINICAL CASE OF VASOSPASTIC ANGINA IN A PATIENT WITH GASTROESOPHAGEAL REFLUX DISEASE
by: Irina Vladimirovna Ponomarenko, et al.
Published: (2023-09-01)

THE DYNAMICS OF LIFE QUALITY PARAMETERS WITH NICORANDIL USAGE IN STABLE CORONARY HEART DISEASE PATIENTS (RESULTS OF THE OBSERVATION STUDY “NIKEA”)
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

Nitrates in complex angina management during the age of aggressive coronary atherosclerosis treatment
by: D. M. Aronov, et al.
Published: (2005-10-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

Various protocols of extracorporeal shock wave therapy in the treatment of stable angina
by: M. M. Shcherbak, et al.
Published: (2019-11-01)

Antagonisty kal'tsiya v lechenii arterial'noy gipertonii (issledovanie ETNA)
by: I E Chazova, et al.
Published: (2005-03-01)

Diagnostic assessment of endothelial function in metabolic syndrome and coronary heart disease
by: V. A. Nevzorova, et al.
Published: (2011-04-01)

COMPLEX APPROACHES TO TREATMENT OF DYSLIPIDEMIA IN PATIENTS WITH ISHEMIC HEART DISEASE
by: M. A. Chichkova, et al.
Published: (2015-10-01)

Relationship between bone mineral density and immune inflammatory parameters in women with osteoporosis concurrent with coronary heart diseases
by: S. Yu. Tsarenok, et al.
Published: (2014-09-01)

Prevalence of ischemic heart disease among males with tuberculosis
by: V A Koshechkin, et al.
Published: (2011-09-01)

Pharmacological correction of pro- and anti-inflammatory cytokine induction and energy metabolism system state in patients with coronary heart disease and chronic heart failure
by: V. E. Malikov, et al.
Published: (2011-10-01)

Predictors of long term adverse events after scheduled endovascular coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-08-01)

Optimized antianginal therapy: a randomized, comparative study of long-acting isosorbide-5-mononitrate and isosorbide dinitrate in patients with coronary heart disease and stable effort angina
by: Yu. E. Semenova, et al.
Published: (2005-08-01)

Nitrate role in cardiovascular disease management: scientific evidence and clinical practice
by: S. R. Gilyarevsky
Published: (2007-06-01)

OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01)

INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS
by: Zh. M. Sizova
Published: (2015-09-01)

Cytokines as inducers of postperfusion systemic inflammatory reaction in cardiosurgical patients with different duration of coronary pathology
by: S. P. Chumakova, et al.
Published: (2018-01-01)

HEMODYNAMIC INSIGNIFICANT CAROTID ARTERIES STENOSIS AND RISK OF EMBOLIC STROKE IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: V. V. Semenova, et al.
Published: (2016-01-01)

EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01)

Differentiation and subpopulation composition of VEGFR2+ cells in the blood and bone marrow in ischemic cardiomyopathy
by: S. P. Chumakova, et al.
Published: (2022-10-01)

Genetic determinants of myocardial electric instability in patients with coronary heart disease undergoing endovascular intervention
by: Yu. I. Afanasiev, et al.
Published: (1970-01-01)

COGNITIVE DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: O. V. Yeremina, et al.
Published: (2014-12-01)

Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)
by: Yu. A. Karpov, et al.
Published: (2021-09-01)

Modern strategy, management and outcomes for stable ischemic heart disease patients
by: V. P. Lupanov
Published: (2016-02-01)

ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
by: M. G. Glezer, et al.
Published: (2013-10-01)

The effect of use simvastatin at treatment of ischemic heart disease patients of senile age
by: A. L. Pirogov, et al.
Published: (2007-10-01)

Psychogenic dyspnea and hypocapnia in men with ischemic heart disease before and after CABG
by: O. V. Grishin, et al.
Published: (2018-06-01)

Clinico-angiographic parallels in patients with coronary atherosclerosis risk factors
by: A. I. Koryakov
Published: (2006-06-01)

ENDOTHELIAL DYSFUNCTION IN STABLE ANGINA AND MYOCARDIAL INFARCTION COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. A. Popova, et al.
Published: (2015-12-01)